Network stress test reveals novel drug potentiators in Mycobacterium tuberculosis

Abstract

Deciphering molecular stress response is highly relevant to studies of microbes such as Mycobacterium tuberculosis (MTB), the causative pathogen of tuberculosis (TB) which sickens 10 million people and kills 1.8 million each year1. Prolonged therapy and unfavorable outcomes arise partially because MTB has evolved stress responses to achieve tolerance, wherein MTB persists in otherwise inhibitory drug concentrations by means independent of heritable resistance mutations2-4. Understanding these adaptations and how they are regulated can reveal new biology, including unexplored drug targets and treatment-enhancing strategies. Here, we present a novel network-based genetic screening approach: the Transcriptional Regulator Induced Phenotype (TRIP) screen, which we used to identify previously uncharacterized MTB network adaptations to the first-line drug isoniazid (INH). We found regulators that alter IN ...